Neoplasia/BPH

	Hematological Inflammation Markers in the Prediction of Clinically Significant Prostate Cancer and the Individualization of Biopsy Decisions for PI-RADS 3 Lesions: A Two-Center Retrospective Study. Prostate Eroglu A, Gezmis CT, Arikan Y, Cilesiz NC, Koras O, Emir B, Balci MBC, Keskin MZ. PMID: 42314010 [PubMed - as supplied by publisher]
	Metabolic Reprogramming in Renal Cell Carcinoma: A Scoping Review with Quantitative Integration of Metabolomic Studies. J Proteome Res Amaro F, Carvalho M, Bastos ML, Guedes de Pinho P, Pinto J. PMID: 42313837 [PubMed - as supplied by publisher]
	Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer: A Nonrandomized Clinical Trial. JAMA Oncol Zilli T, Franzese C, Guckenberger M, Giaj-Levra N, Mach N, Achard V, Vial N, McDonald A, Alongi F, Scorsetti M, Constantin G, Bertaut A, Miralbell R. PMID: 42313395 [PubMed - as supplied by publisher]
	Downregulation of long non-coding RNAs PCAT18, HOTAIR, and CTBP1-AS in prostate malignancies. Mol Biol Rep Pouresmaeili F, Mohammadi M, Hosseini J, Aarabi A, Fazeli Z, Tabatabaie SFS. PMID: 42313281 [PubMed - indexed for MEDLINE]
	Association between the G-protein-coupled estrogen receptor 1 and prostate cancer in the Slovak population. Mol Biol Rep Me, Kliment J, Du, Evin D, Kno, Kme, Dobrota D, Jure. PMID: 42313278 [PubMed - indexed for MEDLINE]
	Preoperative MRI Model for Predicting Inferior Vena Cava Wall Invasion in Renal Cell Carcinoma with Tumor Thrombus. Radiol Imaging Cancer Wen XW, Zhou SP, Kang HH, Zhao J, Bai X, Wang MF, Chen YB, Yi SC, Li CB, Ding XH, Huang QB, Wang HY. PMID: 42313081 [PubMed - indexed for MEDLINE]
	Liver Background Uptake of Prostate-specific Membrane Antigen-targeted PET Radiotracers: A Systematic Review and Meta-Analysis. Radiol Imaging Cancer Ulaner GA, Parihar AS, Calais J, Sutcliffe S, Schoones JW. PMID: 42313080 [PubMed - indexed for MEDLINE]
	The evolution of kidney surgery for renal masses in Switzerland - a retrospective analysis. Swiss Med Wkly Schmid FA, Schütz L, Blum M, Wildisen L, Staehelin K, Mousavi M, Scherer TP, Strebel RT. PMID: 42312990 [PubMed - indexed for MEDLINE]
	Rucaparib - drug evaluation: a PARP inhibitor for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer. Future Oncol Bryce AH, Nash P, Roessler A, Mandair D. PMID: 42312474 [PubMed - as supplied by publisher]
	Metanephric Stromal Tumor of the Kidney in 9-year-old boy: Diagnostic Dilemma and Nephron-Sparing Approach. J Indian Assoc Pediatr Surg Prajapati P, Kumar T, Kumar B, Mathew P. PMID: 42312273 [PubMed]
	1H MR-based detection of human plasma metabolic alterations in clear cell renal cell carcinoma. BJUI Compass Sharma RK, Solaiyappan M, Feinaj A, Brönimann S, Singla N, Bhujwalla ZM, Ged Y. PMID: 42311813 [PubMed]
	Gold Nanoparticle Radiosensitization for High-Dose-Rate Brachytherapy: Differential Efficacy of PEG- and RGD-Functionalized Gold Nanoparticles Across 2-Dimensional, 3-Dimensional, and in vivo Prostate Cancer Models. Int J Nanomedicine Cecchi D, Jackson N, Karaman D, Beckham W, Johnstone CD, Lloyd SAM, Chithrani D. PMID: 42311423 [PubMed - indexed for MEDLINE]
	Liquid biopsy-guided kidney-sparing management in upper tract urothelial carcinoma: from preoperative risk stratification to perioperative surveillance. Front Oncol Yu D, Tang J, Zhang Y, Hu K, Qing J, Zhang J. PMID: 42311269 [PubMed]
	Prostate cancer research on social media platforms: a bibliometric and thematic analysis. Front Oncol Xie Y, Huang H, Chen X, Chen L, Guo Z. PMID: 42311243 [PubMed]
	MYC gene amplification drives protein overexpression and its clinical prognostic value in prostate cancer: a study of 152 Chinese cases. Am J Clin Pathol Tang M, Xie C, Huang R, Lei C, Yu X, Zhou P. PMID: 42310904 [PubMed - indexed for MEDLINE]
	AI-Assisted Prostate Cancer Diagnosis Using Biparametric MRI and PI-RADS v2.1: Performance Comparison Between Novice-Level and Experienced Readers. J Magn Reson Imaging Li K, Mi S, Chen L, Jiang M, Wang B, Huang Y, Wang Y, Fei G, Fu K. PMID: 42309979 [PubMed - as supplied by publisher]
	Comparison FT-IR spectral fingerprints of kidney Cancer in urine and serum: Clinical correlations and diagnostic potential. Spectrochim Acta A Mol Biomol Spectrosc Mitura P, Odrzywolski A, Gumbarewicz E, Godzisz M, Kuliniec I, Depciuch J. PMID: 42309029 [PubMed - as supplied by publisher]
	Assessment of Tumor Microenvironment Inflammatory Biomarkers in Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors. Clin Genitourin Cancer Drüke L, Schmitz J, Vicente MM, Vasileiadis N, Christensen D, Maulhardt M, Kuczyk MA, Tezval H, Darr C, Grünwald V, Ivanyi P, Bräsen JH. PMID: 42308960 [PubMed - as supplied by publisher]
	Quantitative Histogram Analysis of 5.0T Multiparametric MRI for Discrimination Between Prostate Cancer and Benign Hyperplasia. Technol Cancer Res Treat Zheng C, Xing S, Liu X, Xiang S, Xiong Y, Ma H, Emu Y, Zeng W. PMID: 42308481 [PubMed - indexed for MEDLINE]
	CT Perfusion Blood Flow Provides an Early Response Marker for Progression-free Survival in a Prospective Randomized Clinical Trial of Metastatic Renal Cell Carcinoma. Technol Cancer Res Treat Ng CS, Chen Y, Wei W, Chandler AG, Hobbs BP, Tannir NM. PMID: 42308169 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 188730

Page 1 of 9437



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy